Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Saturn Oil & Gas Inc. Announces its First Development of Cardium Wells at Brazeau and Continued Successful Development (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Cardiol Therapeutics Inc T.CRDL

Alternate Symbol(s):  T.CRDL.W.A | CRDL

Healthcare
Cardiol Therapeutics Inc. (Cardiol) is a Canada-based clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). The Company's lead product, CardiolRx, is a pharmaceutically produced oral cannabidiol formulation that is in a Phase II/III study in hospitalized patients testing positive... see more

TSX:CRDL - Post Discussion

Cardiol Therapeutics Inc > New Buy recommendation with $15.77 Target
View:
Post by Youhillman on Jun 23, 2021 9:47am

New Buy recommendation with $15.77 Target

Just caught the attached as it was published today. 

Solid recommendation by this German firm where CRDL is listed. It's the highest target price I have seen to date.

Personally I'm waiting for the NASDAQ listing news, it could be this month or early next month based on comments recently made by the CEO, in fact he is doing a Renmark call today at noon, hopefully we get an update.  

A NASDAQ listing will double the current price of CRDL.

I'm long on CRDL!

https://www.marketscreener.com/quote/stock/CARDIOL-THERAPEUTICS-INC-49649129/news/Original-Research-nbsp-Cardiol-Therapeutics-von-GBC-AG-BUY-35681247/

Comment by Youhillman on Jun 23, 2021 11:28am
Just received a more complete analyst report vs. the link I sent earlier today, I hope you find it beneficial!
Comment by Youhillman on Jun 23, 2021 12:52pm
https://www.more-ir.de/d/22609.pdf
Comment by NewFanCBD on Jun 26, 2021 5:55pm
Thank you You!
Comment by NewFanCBD on Jun 26, 2021 5:22pm
This $15.77 price target from Germany may get hit early next year but I'm holding up for my $8.00 dollar price point for 2021. Buckle up everyone. 
Cardiol Therapeutics Inc